BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8332893)

  • 1. Intrigue grows around Redfield report.
    Science; 1993 Jul; 261(5119):283. PubMed ID: 8332893
    [No Abstract]   [Full Text] [Related]  

  • 2. Army expected to clear AIDS scientist.
    Science; 1993 Jul; 261(5117):19. PubMed ID: 8316847
    [No Abstract]   [Full Text] [Related]  

  • 3. Army clears Redfield--but fails to resolve controversy.
    Cohen J
    Science; 1993 Aug; 261(5123):824-5. PubMed ID: 8346432
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individuals.
    Zunich KM; Lane HC; Davey RT; Falloon J; Polis M; Kovacs JA; Masur H
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1335. PubMed ID: 1466952
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic approaches to the therapy of HIV-1 infection.
    Sneller MC; Lane HC
    Ann N Y Acad Sci; 1993 Jun; 685():687-96. PubMed ID: 8363275
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS vaccines. Army investigates researcher's report of clinical trial data.
    Cohen J
    Science; 1992 Nov; 258(5084):883-4. PubMed ID: 1439797
    [No Abstract]   [Full Text] [Related]  

  • 7. The true cost of a free AIDS vaccine.
    Science; 1993 Aug; 261(5125):1107. PubMed ID: 8356442
    [No Abstract]   [Full Text] [Related]  

  • 8. Army to test only MicroGeneSys vaccine.
    Science; 1993 Aug; 261(5123):819. PubMed ID: 8346429
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccines repress HIV in children.
    AIDS Patient Care STDS; 1996 Dec; 10(6):381. PubMed ID: 11361573
    [No Abstract]   [Full Text] [Related]  

  • 10. A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunization.
    Coulaud IP; Gougeon ML; Gomard E; Descamps D; Lebon P; Aboulker JP; Bizzini B; Zagury D
    AIDS; 1997 Jun; 11(7):937-8. PubMed ID: 9189226
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic HIV vaccine from Spain.
    Burton A
    Lancet Infect Dis; 2001 Dec; 1(5):291. PubMed ID: 11871794
    [No Abstract]   [Full Text] [Related]  

  • 12. AIDS vaccine trial disappointing.
    Science; 1996 Apr; 272(5260):341. PubMed ID: 8602519
    [No Abstract]   [Full Text] [Related]  

  • 13. Progress in development and testing of novel recombinant vaccine platforms for HIV.
    Weiner DB
    Springer Semin Immunopathol; 2006 Nov; 28(3):195-6. PubMed ID: 17043866
    [No Abstract]   [Full Text] [Related]  

  • 14. Remune trials recruiting.
    PI Perspect; 1996 Sep; (No 19):17. PubMed ID: 11363901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 30 years of AIDS vaccine research.
    IAVI Rep; 2011; 15(3):9-12. PubMed ID: 21809799
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccines for control of HIV infections.
    Sharma KB
    J Indian Med Assoc; 1994 Jan; 92(1):27-8. PubMed ID: 8207277
    [No Abstract]   [Full Text] [Related]  

  • 17. HHS fumbles ball on AIDS vaccine trial.
    Science; 1993 Jul; 261(5118):151. PubMed ID: 8327883
    [No Abstract]   [Full Text] [Related]  

  • 18. Congress seeks files on gp160 vaccine.
    Science; 1993 Oct; 262(5133):495. PubMed ID: 8211169
    [No Abstract]   [Full Text] [Related]  

  • 19. Endgame for MicroGeneSys vaccine trial?
    Science; 1993 Dec; 262(5140):1635. PubMed ID: 8259501
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications of the SILCAAT and ESPRIT trials and the future for HIV immunotherapy.
    Peters BS; Samuel M
    J HIV Ther; 2010 Mar; 15(1):15-7. PubMed ID: 21180234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.